Susan M. Molineaux

Founder, President & Chief Executive Officer at Calithera Biosciences, Inc.

Susan M. Molineaux

Susan M. Molineaux

Founder, President & Chief Executive Officer at Calithera Biosciences, Inc.

Overview
Career Highlights

Calithera Biosciences, Inc.
Proteolix, Inc.

RelSci Relationships

707

Number of Boards

7

Birthday

1954

Age

65

Contact Data
Trying to get in touch with Susan M. Molineaux? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Susan M. Molineaux likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Vice President of Development at Calithera Biosciences, Inc.

Relationship likelihood: Strong

Executive Vice Chair at San Francisco Conservatory of Music

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Geron Corp.

Relationship likelihood: Strong

Former Interim Executive Chairman at Geron Corp.

Relationship likelihood: Strong

General Partner at Advanced Technology Ventures

Relationship likelihood: Strong

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Former Postdoctoral, Department of Biochemistry at Stanford University - School of Medicine

Relationship likelihood: Strong

Chief Executive Officer at Neoleukin Therapeutics, Inc.

Relationship likelihood: Strong

Former Executive Vice President, Chief Financial Officer & Chief Accounting Officer at Sangamo Therapeutics, Inc.

Relationship likelihood: Strong

Director of Translational Science at Calithera Biosciences, Inc.

Relationship likelihood: Strong

Paths to Susan M. Molineaux
Potential Connections via
Relationship Science
You
Susan M. Molineaux
Founder, President & Chief Executive Officer at Calithera Biosciences, Inc.
Family Members
Spouse
Senior Vice President of Development at Calithera Biosciences, Inc.

Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Education
B.S. in Biology
Class of 1975

Since its founding in 1871, Smith College has provided women of high ability and promise an education of uncompromising quality. A world-class faculty of scholars are fully engaged with their students' intellectual development, and an open curriculum encourages each student to explore many fields of knowledge. Mentors for scholarship, leadership and service, across all spectrums of endeavor, allow Smith students to observe different models of achievement, then set their own course with conviction.

PhD in Molecular Biology

The Johns Hopkins University opened in 1876, with the inauguration of its first president, Daniel Coit Gilman. "What are we aiming at?" Gilman asked in his installation address. "The encouragement of research ... and the advancement of individual scholars, who by their excellence will advance the sciences they pursue, and the society where they dwell." The mission laid out by Gilman remains the university's mission today, summed up in a simple but powerful restatement of Gilman's own words: "Knowledge for the world." What Gilman created was a research university, dedicated to advancing both students' knowledge and the state of human knowledge through research and scholarship. Gilman believed that teaching and research are interdependent, that success in one depends on success in the other. A modern university, he believed, must do both well. The realization of Gilman's philosophy at Johns Hopkins, and at other institutions that later attracted Johns Hopkins-trained scholars, revolutionized higher education in America, leading to the research university system as it exists today. After more than 130 years, Johns Hopkins remains a world leader in both teaching and research. Eminent professors mentor top students in the arts and music, the humanities, the social and natural sciences, engineering, international studies, education, business and the health professions. Those same faculty members, and their research colleagues at the university's Applied Physics Laboratory, have each year since 1979 won Johns Hopkins more federal research and development funding than any other university. The university has nine academic divisions and campuses throughout the Baltimore-Washington area. The Krieger School of Arts and Sciences, the Whiting School of Engineering, the School of Education and the Carey Business School are based at the Homewood campus in northern Baltimore. The schools of Medicine, Public Health, and Nursing share a campus in east Baltimore with The Johns Hopkins Hospital. The Peabody Institute, a leading professional school of music, is located on Mount Vernon Place in downtown Baltimore. The Paul H. Nitze School of Advanced International Studies is located in Washington's Dupont Circle area. The Applied Physics Laboratory is a division of the university co-equal to the nine schools, but with a non-academic, research-based mission. APL, located between Baltimore and Washington, supports national security and also pursues space science, exploration of the Solar System and other civilian research and development. Johns Hopkins also has a campus near Rockville in Montgomery County, Md., and has academic facilities in Nanjing, China, and in Bologna, Italy. It maintains a network of continuing education facilities throughout the Baltimore-Washington region, including centers in downtown Baltimore, in downtown Washington and in Columbia. When considered in partnership with its sister institution, the Johns Hopkins Hospital and Health System, the university is Maryland's largest employer and contributes more than $10 billion a year to the state's economy

Career History
Founder, President & Chief Executive Officer
2010 - Current

Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Co-Founder
2003 - 2009

Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA

Vice President-Biology
2000 - 2003

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Boards & Committees
Director
Prior - 2016

California Biomedical Innovation Alliance is a private company headquartered in South San Francisco, CA, that provides biomedical advocacy and community services. Sara Radcliffe is currently the CEO of the firm.The company says this about itself: California Life Sciences Association (CLSA) is the state's largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California's life sciences economy. CLSA serves bio technology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

Investments
Details Hidden

Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Details Hidden

Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Susan M. Molineaux. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Susan M. Molineaux's profile does not indicate a business or promotional relationship of any kind between RelSci and Susan M. Molineaux.